General InformationSyneron Bio is a California-based clinical-stage biopharmaceutical company focused on cell and gene therapies, founded in 2014, with approximately 51-200 employees.
Funding & FinancialsThe company has raised multiple rounds of institutional funding with Series B as the most recent disclosed stage, backed by biotech-focused venture investors.
Leadership & TeamSyneron Bio is led by experienced biotech executives with backgrounds in cell therapy and oncology, though specific current leadership details require verification from recent company announcements.
Recent ActivityThe company continues advancing its pipeline of cell and gene therapy candidates through clinical development, with ongoing focus on expanding its therapeutic platform capabilities.